| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |